Italy
Center of Excellence
Faculty
Matteo Lambertini, MD PhD, University of Genova
WORK EXPERIENCES
January 2019-Present: Assistant Professor, Consultant in Medical Oncology, Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino- University of Genova, Genova (Italy)
January 2016-December 2018: Clinical Research Associate-ESMO Translational Research Fellow, Medical Oncology Department, Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels (Belgium)
June 2011-June 2016: Specialty in Medical Oncology at the Medical Oncology Department, IRCCS AOU San Martino-IST, Genova (Italy)
January 2015-Febraury 2015: Visiting Researcher, Medical Oncology Department, Thomas Jefferson University, Philadelphia, PA
July 2014-December 2014: Visiting Researcher, Medical Oncology Department, Adult Survivorship Programme, Dana-Farber Cancer Institute, Boston, MA
August 2013-September 2013: ESMO Clinical Unit Visit, Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Brussels (Belgium)
December 2010-June 2011: Contractor at the S.S. Sviluppo Terapie Innovative, IST – National Cancer Institute, Genova (Italy)
October 2008-November 2010: Trainee at the Medical Oncology Division, IST – National Cancer Institute, Genova (Italy)
PUBLICATIONS
201 publications in peer-review journals (69 as first author); selected 5 publications:
Lambertini M et al. “Pregnancy after breast cancer in patients with germline BRCA mutations”. J Clin Oncol. 2020;38(26):3012-23
Lambertini M et al. “Adjuvant anti-HER2 therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients”. J Natl Cancer Inst. 2019;111(1);86-94
Lambertini M et al. “Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data”. J Clin Oncol. 2018;36(19):1981-90
Lambertini M et al. “Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients”. Ann Oncol. 2018;29:237-243
Lambertini M et al. “Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease- free survival: a randomized clinical trial”. JAMA. 2015;314:2632-40
ORAL ABSTRACT PRESENTATION
80 abstracts at International conferences (26 as first author and 13 as last author) and 46 abstracts at National conferences (7 as first author and 4 as last author). Selected 5 oral abstract presentations:
“Safety of pregnancy following breast cancer (BC) in patients (pts) carrying a BRCA mutation (mBRCA): results of an international cohort study”. 2019 ASCO Annual Meeting, 3 June 2019, Chicago, IL (USA)
“Pooled analysis of five randomized trials investigating temporary ovarian suppression with gonadotropin-releasing hormone analogs during chemotherapy as a strategy to preserve ovarian function and fertility in premenopausal early breast cancer patients”. 2017 SABCS, 7 December 2017, San Antonio, TX (USA)
“Reproductive potential and performance of fertility-preserving procedures in BRCA mutation-positive breast cancer patients”. ESMO 2017 Congress, 9 September 2017, Madrid (Spain)
“Dose-dense adjuvant chemotherapy, treatment-induced amenorrhea and overall survival in premenopausal breast cancer patients: a pooled analysis of the MIG1 and GIM2 phase III studies”. European Breast Cancer Conference (EBCC)-10, 10 March 2016, Amsterdam (The Netherlands)
“Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients”. 2014 ASCO Breast Cancer Symposium, 4- 7 September 2014, San Francisco, CA (USA)
HONORS AND AWARDS
2019 Conquer Cancer Foundation of ASCO Merit Award at the 2019 ASCO Annual Meeting in Chicago, IL (USA)
• 2018 Conquer Cancer Foundation of ASCO Merit Award at the 2018 ASCO Annual Meeting in Chicago, IL (USA)
• 2017 SABCS Clinical Scholar Award at the San Antonio Breast Cancer Symposium, San Antonio, TX (USA)
• 2017 Conquer Cancer Foundation of ASCO Merit Award at the 2017 ASCO Annual Meeting in Chicago, IL (USA)
• ESMO Translational Research Fellowship – Institut Jules Bordet, from August 2016 onwards, Brussels (Belgium)
• “Marco Venturini” Award Lecture – XVIII Italian National Oncology AIOM Conference, 28-30 October 2016 in Rome (Italy)
• Best publication by a young oncologist – Annual National Congress of the AIOM Young Oncologist Committee, 28-30 October 2016 in Perugia (Italy)
• Best abstract – oral presentation at the “ESO (European School of Oncology) BCY2 – 2nd Breast Cancer in Young Women Conference”, 4-5 November 2014, Dublin (Ireland)
• Best oral presentation at the XVI Italian National Oncology Conference, 24-26 October 2014 in Rome (Italy)
• 2014 Conquer Cancer Foundation of ASCO Merit Award at the 2014 ASCO Breast Cancer Symposium in San Francisco, CA (USA)
• 2014 Conquer Cancer Foundation of ASCO Merit Award at the 2014 ASCO Annual Meeting in Chicago, IL (USA)
• ESMO Clinical Unit Visit Fellowship – Institut Jules Bordet, from 19 August 2013 to 27 September 2013, Brussels (Belgium)
• ESMO Translational Research Unit Visit Fellowship (“Lost in Translation: How to find your way”) – The Christie NHS Foundation Trust, 21-23 November 2012, Manchester (United Kingdom)
• Honorable mention – poster presentation at the “ESO BCY1 – Breast Cancer in Young Women Conference”, 8-10 November 2012, Dublin (Ireland)